Progress in Clinical Neuropsychology and Neurorehabilitation

Dear Colleagues,

According to the National Academy of Neuropsychology (NAN), clinical neuropsychology uses our current knowledge of the brain–behavior relationship ‘in the assessment, diagnosis, treatment, and/or rehabilitation of patients across the lifespan with neurological, medical, neurodevelopmental and psychiatric conditions, as well as other cognitive and learning disorders’. A plethora of patients suffering from disorders such as stroke, Traumatic Brain Injury (TBI), multiple sclerosis (MS), epilepsy, and amyotrophic lateral sclerosis (ALS) can benefit from neurorehabilitation, and new approaches and protocols are being proposed, tested and used every day. Despite major advances in the methods and findings in this field in recent years, different neurorehabilitation theories, methods and techniques open new discussions over the methodologies of these interventions, as well as their results in different cultural contexts.

We are pleased to invite you to provide clinicians and researchers with evidence-based recommendations regarding relevant interventions across the lifespan and a range of disorders, as well as on outcome measures which should be used in rehabilitation. In addition, review articles describing the current state of the art in neurorehabilation and cross-cultural replication studies are welcome.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:

• Systematic reviews and meta-analyses of existing interventions and assessment tools in neurorehabilitation;
• New empirical research;
• Psychometric studies measuring the psychometric characteristics of assessment tools;
• Comparative studies of different assessment tools measuring the same area;
• Cross-cultural studies regarding existing or new interventions and/or findings of replication studies.

I look forward to receiving your contributions.

Yours faithfully,

Dr. Vaitsa Giannouli
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• clinical neuropsychology
• neurorehabilitation
• stroke
• traumatic brain injury (TBI)
• concussion
• multiple sclerosis (MS)
• epilepsy
• Parkinson’s disease (PD)
• spasticity
• spinal cord injuries
• movement disorders
• neuromuscular diseases
• amyotrophic lateral sclerosis (ALS)
• neurological disorders
• Alzheimer’s disease (AD)
• children
• older patients